EB
TEVA icon

Eastern Bank’s Teva Pharmaceuticals TEVA Stock Holding History

Eastern Bank’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,000
Closed -$31.2K – 1212
2025
Q4 		$31.2K Hold
1,000
– – ﹤0.01% 650
2025
Q3 		$20.2K Hold
1,000
– – ﹤0.01% 726
2025
Q2 		$16.8K Hold
1,000
– – ﹤0.01% 702
2025
Q1 		$15.4K Hold
1,000
– – ﹤0.01% 733
2024
Q4 		$22K Buy
+1,000
New +$18.2K ﹤0.01% 680
2016
Q4 		– Sell
-37,985
Closed -$1.75M – 204
2016
Q3 		$1.75M Sell
37,985
-947
-2% -$49.4K 0.14% 102
2016
Q2 		$1.96M Buy
38,932
+1,609
+4% +$85.7K 0.16% 98
2016
Q1 		$2M Buy
37,323
+1,016
+3% +$59.6K 0.16% 97
2015
Q4 		$2.38M Sell
36,307
-628
-2% -$38.8K 0.2% 84
2015
Q3 		$2.08M Buy
+36,935
New +$2.39M 0.18% 89
2013
Q4 		– Sell
-7,882
Closed -$297K – 212
2013
Q3 		$297K Sell
7,882
-45
-0.6% -$1.75K 0.03% 177
2013
Q2 		$310K Buy
+7,927
New +$309K 0.03% 166

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Eastern Bank's TEVA Position: Q1 2026 in Review

Eastern Bank sold out of Teva Pharmaceuticals (TEVA) in Q1 2026, closing a stake of 1,000 shares — an estimated $31.2K sold.

Eastern Bank first reported a position in TEVA in Q2 2013 and held it in 12 quarters. The position peaked at $2.38M in Q4 2015. 652 funds tracked by Wall St. Rank hold TEVA as of Q1 2026.

  • Eastern Bank reported no remaining Teva Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Eastern Bank sold 1,000 Teva Pharmaceuticals shares in Q1 2026, an estimated $31.2K.
  • Eastern Bank first reported a position in Teva Pharmaceuticals in Q2 2013 and held it in 12 quarters.
  • Eastern Bank's Teva Pharmaceuticals position peaked at $2.38M in Q4 2015.
  • 652 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2026.

Based on Eastern Bank's 13F filing for Q1 2026, filed 7 Apr 2026.